Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.005 USD -16.67% Market Closed
Market Cap: 16.3m USD
Have any thoughts about
Medivolve Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one MEDVF stock under the Base Case scenario is 0.001 USD. Compared to the current market price of 0.005 USD, Medivolve Inc is Overvalued by 88%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDVF Relative Value
Base Case
0.001 USD
Overvaluation 88%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

24
P/S
P/S
Price to Sales
24
vs History
25
vs Industry
Median 3Y
14.9
Median 5Y
6.7
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-6.8
Median 5Y
-11.7
Industry
23.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-24.1
Median 5Y
-33
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-17.9
Median 5Y
-23.5
Industry
20.1
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
7.6
Industry
2.2
More Details
25.3
EV/S
EV/S
Enterprise Value to Sales
25.3
vs History
25
vs Industry
Median 3Y
15.1
Median 5Y
6.7
Industry
2.4
More Details
29.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
29.4
vs History
34
vs Industry
Median 3Y
27.7
Median 5Y
27.2
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-10.7
Median 5Y
-17.4
Industry
12.8
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-9.6
Median 5Y
-15.5
Industry
17.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-32.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-32.6
Industry
18.2
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
9.6
Median 5Y
42.8
Industry
1.9
More Details

Multiples Across Competitors

MEDVF Competitors Multiples
Medivolve Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Medivolve Inc
OTC:MEDVF
16.3m USD 24 -1.3 -7 -6.4
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9
P/E Multiple
Earnings Growth PEG
CA
Medivolve Inc
OTC:MEDVF
Average P/E: 25.1
Negative Multiple: -1.3 		N/A N/A
US
C
Cigna Group
XMUN:CGN
25.7
25%
1
US
Cigna Corp
NYSE:CI
25.4
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
39.2
31%
1.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.3 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.1
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.2
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
19.7
31%
0.6
US
DaVita Inc
NYSE:DVA
14.9
17%
0.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Medivolve Inc
OTC:MEDVF
Average EV/EBIT: 23.4
Negative Multiple: -6.4 		N/A N/A
US
C
Cigna Group
XMUN:CGN
10.4
10%
1
US
Cigna Corp
NYSE:CI
10.3
10%
1
US
CVS Health Corp
NYSE:CVS
9.6
-1%
N/A
DE
Fresenius Medical Care AG
XMUN:FME
23.1
22%
1.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
19
34%
0.6
US
Laboratory Corporation of America Holdings
NYSE:LH
20.3
25%
0.8
US
R1 RCM Inc
NASDAQ:RCM
99.1
10%
9.9
US
Quest Diagnostics Inc
NYSE:DGX
16.5
11%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
14.3
22%
0.6
US
DaVita Inc
NYSE:DVA
10.9
10%
1.1

See Also

Summary
MEDVF intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDVF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDVF stock valuation using valuation multiples.
Wall Street Estimates
MEDVF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDVF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.